<DOC>
	<DOCNO>NCT01095263</DOCNO>
	<brief_summary>The investigator investigate sham control design antidepressant effect safety DBS superolateral branch main medial forebrain bundle ( slMFB ) .</brief_summary>
	<brief_title>Effects Deep Brain Stimulation Treatment Resistant Major Depression</brief_title>
	<detailed_description>The target point DBS major depression disorder locate lateral ventral tegmental area ( VTA ) midbrain branch point superolateral branch ( slMFB ) main medial forebrain bundle ( MFB ) . The exact stimulation coordinate : MNI152 coordinate : left : x ( lat . ) =-5 , ( ap ) =-14 , z ( vert . ) =-8 right : x ( lat . ) =5 , ( ap ) =-14 , z ( vert . ) =-9 MCP coordinate : eft : x ( lat . ) =-6 , ( ap ) =-1 , z ( vert . ) =-6 right : x ( lat . ) =4 , ( ap ) =-1 , z ( vert . ) =-7 All coordinate refer MNI152 brain . Legend : slMFB = superolateral branch medial forebrain bundle , MNI152=Montreal Neurologic Institute brain 152 coordinate , MCP = mid-commissural point coordinate , lat . = lateral , ap= antero-posterior , vert . = vertical . More information find : http : //goo.gl/n9sWV In addition describe intervention , record EEG activity within implanted region cognitive paradigm ( Fell Axmacher , Nat Rev Neurosci 2011 ) . Specifically , investigate neural mechanism underlie classification learning , work memory exploration reward spatial location explore oscillatory response follow stimulation target region . These experimental paradigm conduct first day electrode implantation .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Major depression ( MD ) , severe , unipolar type German mother tongue Hamilton Depression Rating Scale ( HDRS24 ) score &gt; 20 Global Assessment Function ( GAF ) score &lt; 45 At least 4 episode MD chronic episode &gt; 2 year &gt; 5 year first episode MD Failure respond adequate trial ( &gt; 5 week maximum recommend tolerate dose ) primary antidepressant least 3 different class ; adequate trial ( &gt; 3 week usually recommend maximum tolerated dose ) augmentation/combination primary antidepressant use least 2 different augmenting/combination agent ( lithium , T3 , stimulant , neuroleptic , anticonvulsant , buspirone , second primary antidepressant ) ; adequate trial electroconvulsive therapy [ ECT ] ( &gt; 6 bilateral treatment ) ; adequate trial individual psychotherapy ( &gt; 20 session experienced psychotherapist ) . Able give write informed consent No medical comorbidity Drug free stable drug regimen least 6 week study entry Current past nonaffective psychotic disorder Any current clinically significant neurological disorder medical illness affect brain function , motor tic Gilles de la Tourette syndrome Any clinically significant abnormality preoperative magnetic resonance imaging ( MRI ) Any surgical contraindication undergo DBS Current unstably remit substance abuse ( aside nicotine ) Pregnancy woman childbearing age use effective contraception History severe personality disorder</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>